CIK 0001661053 · Non-accelerated filer<br>Smaller reporting company
enVVeno Medical Corp
Sign in to watch- Ticker
- NVNO
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330936180
- Phone
- 949-261-2900
- Business address
- 70 DOPPLER, IRVINE, CA, 92618
- Former names
- Hancock Jaffe Laboratories, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $123
- in 1 filing, $123 under 10b5-1 plans
Net −$123. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-12-18 | BERMAN ROBERT ANDREW Chief Executive Officer | Grant or award · Stock Options | +200,000 | 200,000 | ||
| 2024-12-18 | Jenusaitis Matthew Director | Grant or award · Stock Options | +19,752 | 19,752 | ||
| 2024-12-18 | Glickman Marc H. SVP & Chief Medical Officer | Grant or award · Stock Options | +75,000 | 75,000 | ||
| 2024-12-18 | Alavi Hamed Chief Technology Officer | Grant or award · Stock Options | +75,000 | 75,000 | ||
| 2024-12-18 | Duhay Francis Director | Grant or award · Stock Options | +19,752 | 19,752 | ||
| 2024-03-13 | Alavi Hamed Chief Technology Officer | Option exercise | +8,334 | $3.59 | $30K | 8,334 |
| 2024-03-13 | Alavi Hamed Chief Technology Officer | Sale | −8,334 | $6.22 | $52K | 0 |
| 2024-03-13 | Alavi Hamed Chief Technology Officer | Option exercise · Stock Options | −8,334 | 91,666 | ||
| 2023-12-05 | Glynn Craig Chief Financial Officer | Grant or award · Stock Options | +75,000 | 75,000 | ||
| 2023-12-05 | Shrivastava Sanjay Director | Grant or award · Stock Options | +13,856 | 13,856 | ||
| 2023-12-05 | Jenusaitis Matthew Director | Grant or award · Stock Options | +13,856 | 13,856 | ||
| 2023-12-05 | Gray Robert Director | Grant or award · Stock Options | +13,856 | 13,856 | ||
| 2023-12-05 | Glickman Marc H. SVP & Chief Medical Officer | Grant or award · Stock Options | +100,000 | 100,000 | ||
| 2023-12-05 | Duhay Francis Director | Grant or award · Stock Options | +13,856 | 13,856 | ||
| 2023-12-05 | BERMAN ROBERT ANDREW Chief Executive Officer | Grant or award · Stock Options | +300,000 | 300,000 | ||
| 2023-12-05 | Alavi Hamed Chief Technology Officer | Grant or award · Stock Options | +100,000 | 100,000 | ||
| 2022-11-30 | Duhay Francis Director | Grant or award · Stock Options | +8,403 | 8,403 | ||
| 2022-11-30 | Gray Robert Director | Grant or award · Stock Options | +8,403 | 8,403 | ||
| 2022-11-30 | Jenusaitis Matthew Director | Grant or award · Stock Options | +8,403 | 8,403 | ||
| 2022-11-30 | Shrivastava Sanjay Director | Grant or award · Stock Options | +8,403 | 8,403 |
Page 2 of 8 · 141 trades